Sotac Pharmaceuticals Ltd.

View in App
130.60 0.00

30 November 2023, 12:15:52 PM
Volume: 1,200

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.sotacpharma.com
Market Cap 144.31 Cr.
Enterprise Value(EV) 165.33 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 2.07 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 63.13 Trailing Twelve Months Ending 2023-03
Industry PE 38.14 Trailing Twelve Months Ending 2023-03
Book Value / Share 40.07 Trailing Twelve Months Ending 2023-03
Price to Book Value 3.26 Calculated using Price: 130.60
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.11 Cr. 11,050,000 Shares
FaceValue 10
About Sotac Pharmaceuticals Ltd.
The company specializes in the production of high-quality pharmaceutical products on a loan license or contract manufacturing basis. It has a diverse product portfolio that includes a wide range of pharmaceuticals, nutraceuticals, and food products.

Sotac Pharmaceuticals Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Sotac Pharmaceuticals Ltd. Performance

View details >>
1 Day
1 Week
-1.80%
1 Month
+13.57%
3 Month
+7.80%
6 Month
-6.58%
1 Year
2 Year
5 Year
10 Year

Sotac Pharmaceuticals Ltd. Fundamental Ratios

View details >>
4 years 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 2.86 -85.23 63.16 27.53
Return on Capital Employed (%) 4.18 -5.71 31.31 21.50
Return on Assets (%) 0.29 -7.27 8.23 4.20

Sotac Pharmaceuticals Ltd. Balance Sheet

View details >>
Particulars 5 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 3 2 7 19 43
Non Curr. Liab. 6 9 1 8 8
Curr. Liab. 19 23 28 46 43
Minority Int. 2 0 0 5
Equity & Liab. 30 35 35 74 99
Non Curr. Assets 17 17 9 27 39
Curr. Assets 14 17 26 47 60
Misc. Exp. not W/O
Total Assets 30 35 35 74 99

Sotac Pharmaceuticals Ltd. Profit and Loss

View details >>
Particulars 4 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Net Sales 29 49 73 77
Other Income 0 0 0 0
Total Income 29 49 73 78
Total Expenditure -27 -47 -67 -70
PBIDT 2 2 6 8
Interest 0 -1 -1 -2
Depreciation -1 -3 -1 -2
Taxation 0 0 -2 -2
Exceptional Items 1
PAT 0 -2 3 2
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 0 -2 3 2
Adjusted EPS 0 -3 4 3

Sotac Pharmaceuticals Ltd. Cash Flow

View details >>
Particulars 4 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 6 8
Cash Fr. Inv. -12 -3 -4 -12
Cash Fr. Finan. 11 3 -3 13
Net Change 0 0 10
Cash & Cash Eqvt 0 0 0 10

Sotac Pharmaceuticals Ltd. Shareholding Pattern

View details >>
1 Qtrs 2023-09 (%)
Promoter 72.85
Public 27.15
Depository Receipts 0.00
Promoter Holding Pledge (%) 0.00

Sotac Pharmaceuticals Ltd. Announcements

View details >>

No Corporate Announcement found.

Sotac Pharmaceuticals Ltd. Technical Scans

View details >>
Tue, 28 Nov 2023
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Closing Above Previous High Closing Above Previous High
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Above Last Month High Close Above Last Month High

Sotac Pharmaceuticals Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 288,124.14 1,218.15 +1.3%
Divi's Laboratories Ltd. 98,985.27 3,799.00 +1.9%
Cipla Ltd. 97,035.44 1,201.70 +0.0%
Dr. Reddy's Laboratories Ltd. 95,335.50 5,752.50 +0.6%
Apollo Hospitals Enterprise Ltd. 77,919.78 5,506.75 +1.6%
Mankind Pharma Ltd. 76,041.70 1,897.75 0.0%
Torrent Pharmaceuticals Ltd. 70,779.09 2,123.10 +1.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 33.70 1,218.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2023-09 74.33 3,799.00 +1.9%
Cipla Ltd. Consolidated 2023-09 28.10 1,201.70 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.73 5,752.50 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 111.72 5,506.75 +1.6%
Mankind Pharma Ltd. Consolidated 2023-03 59.32 1,897.75 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 53.06 2,123.10 +1.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.82 1,218.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2023-09 7.81 3,799.00 +1.9%
Cipla Ltd. Consolidated 2023-09 3.91 1,201.70 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.74 5,752.50 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 11.99 5,506.75 +1.6%
Mankind Pharma Ltd. Consolidated 2023-03 9.02 1,897.75 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.55 2,123.10 +1.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,218.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,799.00 +1.9%
Cipla Ltd. Consolidated 2023-03 0.02 1,201.70 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,752.50 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,506.75 +1.6%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,897.75 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,123.10 +1.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,218.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,799.00 +1.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,201.70 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,752.50 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,506.75 +1.6%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,897.75 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,123.10 +1.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,218.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,799.00 +1.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,201.70 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,752.50 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,506.75 +1.6%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,897.75 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,123.10 +1.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,218.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,799.00 +1.9%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,201.70 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,752.50 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,506.75 +1.6%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,897.75 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,123.10 +1.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,218.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,799.00 +1.9%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,201.70 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,752.50 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,506.75 +1.6%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,897.75 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,123.10 +1.5%

Sotac Pharmaceuticals Ltd. FAQ's

What is Sotac Pharmaceutical share price?
Can I buy Sotac Pharmaceutical shares now?
What is the Market Cap of Sotac Pharmaceutical?
What are the key metrics to analyse Sotac Pharmaceutical?
What is the 52 Week High and Low of Sotac Pharmaceutical?
What is the trend of Sotac Pharmaceutical share price?